The Pennant Group, Inc.
NASDAQ:PNTGMedical - Care Facilities
-$0.83 today
- Market cap
- $1.26B
- Beta
- 1.27
- P/E (TTM)
- 38.6
- EPS (TTM)
- $0.87
Volume 0.43M
Average 0.25M
PNTG EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
The Pennant Group, Inc.NASDAQ: PNTG
EPS (Diluted) · Q1 FY2026 · quarter ended Mar 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q1 FY2026 EPS (Diluted) of $0.24 rose 9.1% year over year, behind the +11.8% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +56.3% a year.
Context
- EPS (Diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 3 analysts of $1.38 (+64.8%) for the fiscal year ending Dec 2026, a step up from the +18.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $0.24+0.0% QoQ
- Last fiscal yearDec 2025
- $0.84+18.3% YoY
- LTMMar 2026
- $0.85+11.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +9.1% | +65.8% | +56.7 pp |
| 1 year | +18.3% | +64.8% | +46.5 pp |
| 3-year CAGR | +56.3% | +28.9% | -27.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.84 USD
- Year-over-year change
- +18.3%
- 4-year CAGR
- +86.1%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.84 | +18.3% |
| FY2024 | 2024-12-31 | 0.71 | +61.4% |
| FY2023 | 2023-12-31 | 0.44 | +100.0% |
| FY2022 | 2022-12-31 | 0.22 | +213.8% |
| FY2021 | 2021-12-31 | 0.07 | — |
EPS (Diluted) vs competitors
How PNTG compares with its peers on the latest reported figures
- PNTG's LTM Mar 2026 EPS (Diluted) of $0.85 is the 8th highest of the 11 companies compared; the peer median is $3.69.
- Its year-over-year change of +11.8% is the 7th highest of 11, against a peer median of +18.0%.
- Over three fiscal years its annual growth of +56.3% compares with a peer median of +18.2%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $19.92 | +2.3% | +3.7% | |
| LTM Sep 2026 | $7.24 | +11.7% | +74.2% | |
| LTM Jun 2026 | $6.38 | +15.8% | +13.9% | |
| LTM Jun 2026 | $6.14 | +20.2% | +27.1% | |
| LTM Jun 2026 | $5.7 | +25.8% | +22.4% | |
| LTM Jun 2026 | $1.67 | +103.7% | +6.9% | |
| LTM Oct 2026 | $1.4 | +290.5% | — | |
| LTM Mar 2026 | $0.85 | +11.8% | +56.3% | |
| LTM Sep 2026 | -$0.16 | +87.9% | — | |
| LTM Mar 2026 | -$0.3 | -27.6% | — | |
| LTM Mar 2026 | -$5.83 | -95.0% | — | |
| Peer median (excluding PNTG) | $3.69 | +18.0% | +18.2% | |
Competitors are the stored peer set for PNTG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 439.69M | 473.24M | 544.89M | 695.24M | 947.71M |
| Cost of Revenue | 391.1M | 414.66M | 477.86M | 601.48M | 825.24M |
| Gross Profit | 48.6M | 58.59M | 67.04M | 93.76M | 122.47M |
| Gross Margin | 11.1% | 12.4% | 12.3% | 13.5% | 12.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 36.26M | 33.98M | 36.67M | 50.21M | 71.08M |
| Operating Expenses | 43.9M | 45.85M | 41.87M | 55.65M | 71.08M |
| Depreciation & Amortization | 4.78M | 4.9M | 5.13M | 6.12M | 8.54M |
| EBITDA | 9.46M | 17.61M | 30.64M | 44.44M | 60.85M |
| EBITDA Margin | 2.2% | 3.7% | 5.6% | 6.4% | 6.4% |
| Operating Income | 4.7M | 12.74M | 25.17M | 38.12M | 51.39M |
| Operating Margin | 1.1% | 2.7% | 4.6% | 5.5% | 5.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.94M | 3.82M | 5.92M | 6.96M | 6.68M |
| Other Income / Expenses | (1.97M) | (3.85M) | (5.59M) | (6.75M) | (5.76M) |
| Income Before Tax | 2.73M | 8.89M | 19.58M | 31.37M | 45.63M |
| Pre-Tax Margin | 0.6% | 1.9% | 3.6% | 4.5% | 4.8% |
| Income Tax Expense | 582K | 1.65M | 5.67M | 7.03M | 11.87M |
| Net Income | 2.7M | 6.64M | 13.38M | 22.56M | 29.58M |
| Net Margin | 0.6% | 1.4% | 2.5% | 3.2% | 3.1% |
| EPS (Basic) | 0.08 | 0.23 | 0.45 | 0.72 | 0.86 |
| EPS (Diluted) | 0.07 | 0.22 | 0.44 | 0.71 | 0.84 |
| Weighted Avg Shares | 28.41M | 29.06M | 29.86M | 31.19M | 34.56M |
| Weighted Avg Shares (Diluted) | 30.64M | 30.16M | 30.19M | 32M | 35.32M |
The Pennant Group, Inc.
NASDAQ:PNTG
Intrinsic Alpha fair value
Locked
Current Price
$35.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.